WHO ICTRP trial
Visualizing beta cells in patients with remission of T2DM after bariatric…
EUCTR2014-004317-90-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2014-004317-90-NL |
|---|---|
| Public title | Visualizing beta cells in patients with remission of T2DM after bariatric surgery |
| Scientific title | Visualizing beta cells in patients with remission of T2DM after bariatric surgery - Visualizing beta cells after bariatric surgery |
| Primary sponsor | Radboud University Medical Center Nijmegen |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Netherlands |
| Conditions | Patients with Type 2 Diabetes, with or without remission after bariatric surgery MedDRA version: 17.1 Level: HLGT Classification code 10018424 Term: Glucose metabolism disorders (incl diabetes mellitus) System Organ Class: 10014698… |
| Interventions | Trade Name: Byetta Product Name: 68-Ga-NODAGA-[K40]-Exendin4 Pharmaceutical Form: Radiopharmaceutical precursor, solution |
| Registration date | Jul 1, 2015 |
| Target size | 24 |
| Secondary IDs | NL51058.091.14 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: